LON:PHP - Primary Health Properties PLC (PHP.L) Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 168
  • Forecasted Upside: 10.53 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
GBX 152
▼ -0.4 (-0.26%)
1 month | 3 months | 12 months
Get New Primary Health Properties PLC (PHP.L) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PHP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PHP

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
GBX 168
▲ +10.53% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Primary Health Properties PLC (PHP.L) in the last 3 months. The average price target is GBX 168, with a high forecast of GBX 175 and a low forecast of GBX 155. The average price target represents a 10.53% upside from the last price of GBX 152.
Buy
The current consensus among 5 contributing investment analysts is to buy stock in Primary Health Properties PLC (PHP.L). This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/5/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/4/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/3/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/1/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/30/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
2/17/2021Jefferies Financial GroupBoost Price TargetBuyGBX 168 ➝ GBX 172
i
7/29/2020Peel HuntReiterated RatingAdd
i
7/29/2020Liberum CapitalReiterated RatingBuy
i
7/14/2020Berenberg BankDowngradeHoldGBX 150 ➝ GBX 155
i
7/9/2020Liberum CapitalReiterated RatingBuy
i
7/9/2020Peel HuntReiterated RatingRestricted
i
5/28/2020Peel HuntReiterated RatingAdd
i
5/11/2020Liberum CapitalReiterated RatingBuy
i
5/6/2020Berenberg BankReiterated RatingBuy
i
5/6/2020Peel HuntBoost Price TargetAddGBX 160 ➝ GBX 175
i
4/15/2020Peel HuntReiterated RatingAdd
i
4/15/2020BarclaysReiterated RatingOverweightGBX 168 ➝ GBX 170
i
4/2/2020Jefferies Financial GroupUpgradeBuyGBX 165 ➝ GBX 179
i
4/1/2020Peel HuntReiterated RatingAdd
i
4/1/2020Liberum CapitalReiterated RatingBuy
i
3/25/2020Berenberg BankUpgradeBuy
i
3/18/2020Peel HuntReiterated RatingAdd
i
3/12/2020Peel HuntReiterated RatingAdd
i
2/13/2020BarclaysReiterated RatingOverweightGBX 160 ➝ GBX 168
i
2/12/2020Peel HuntReiterated RatingAddGBX 160
i
2/12/2020Liberum CapitalReiterated RatingBuy
i
2/11/2020Peel HuntReiterated RatingAddGBX 160
i
2/5/2020Peel HuntReiterated RatingAdd
i
2/5/2020Liberum CapitalReiterated RatingBuy
i
1/27/2020Liberum CapitalUpgradeBuyGBX 130 ➝ GBX 185
i
1/17/2020Jefferies Financial GroupDowngradeHoldGBX 147 ➝ GBX 155
i
1/14/2020Peel HuntReiterated RatingAdd
i
1/7/2020Peel HuntReiterated RatingAdd
i
12/17/2019Peel HuntBoost Price TargetAddGBX 145 ➝ GBX 160
i
12/13/2019Jefferies Financial GroupReiterated RatingBuy
i
12/6/2019Liberum CapitalReiterated RatingHold
i
12/3/2019BarclaysInitiated CoverageOverweightGBX 160
i
12/3/2019Peel HuntReiterated RatingAdd
i
11/29/2019Berenberg BankInitiated CoverageHoldGBX 150
i
11/26/2019Peel HuntReiterated RatingAdd
i
11/25/2019Liberum CapitalReiterated RatingHold
i
11/5/2019Peel HuntReiterated RatingAdd
i
10/22/2019Peel HuntReiterated RatingAdd
i
10/15/2019Peel HuntReiterated RatingAdd
i
10/7/2019Peel HuntReiterated RatingAdd
i
9/26/2019Peel HuntReiterated RatingAdd
i
9/24/2019Liberum CapitalReiterated RatingHold
i
9/17/2019Peel HuntReiterated RatingAdd
i
9/10/2019Peel HuntReiterated RatingAdd
i
8/27/2019Peel HuntReiterated RatingAdd
i
8/20/2019Liberum CapitalReiterated RatingHold
i
8/9/2019Peel HuntReiterated RatingAdd
i
7/25/2019Liberum CapitalReiterated RatingHold
i
7/22/2019Peel HuntReiterated RatingAdd
i
7/15/2019Peel HuntReiterated RatingAdd
i
7/9/2019Peel HuntReiterated RatingAdd
i
6/25/2019Peel HuntReiterated RatingAdd
i
6/17/2019Peel HuntDowngradeAddGBX 140 ➝ GBX 145
i
6/11/2019Peel HuntReiterated RatingBuy
i
6/4/2019Peel HuntReiterated RatingBuy
i
5/28/2019Peel HuntReiterated RatingBuy
i
5/14/2019Peel HuntUpgradeBuy
i
5/8/2019Peel HuntUpgradeBuy
i
3/25/2019Liberum CapitalDowngradeHoldGBX 125 ➝ GBX 130
i
3/15/2019Peel HuntReiterated RatingUnder Review
i
1/14/2019Peel HuntReiterated RatingBuy
i
1/9/2019Liberum CapitalReiterated RatingBuy
i
1/4/2019Peel HuntReiterated RatingBuy
i
12/20/2018Peel HuntReiterated RatingBuy
i
12/17/2018Liberum CapitalReiterated RatingBuy
i
12/5/2018Liberum CapitalReiterated RatingBuy
i
10/30/2018Peel HuntReiterated RatingBuyGBX 125
i
10/22/2018Liberum CapitalReiterated RatingBuy
i
9/19/2018Peel HuntReiterated RatingBuy
i
9/5/2018Peel HuntReiterated RatingBuy
i
9/5/2018Liberum CapitalReiterated RatingBuy
i
7/25/2018Peel HuntReiterated RatingBuy
i
7/25/2018Liberum CapitalUpgradeBuy
i
7/12/2018Peel HuntReiterated RatingBuyGBX 125
i
6/11/2018Peel HuntReiterated RatingBuy
i
5/9/2018Peel HuntReiterated RatingBuy
i
5/2/2018Liberum CapitalUpgradeHoldGBX 120
i
4/30/2018Peel HuntReiterated RatingBuyGBX 125
i
4/23/2018Peel HuntReiterated RatingBuyGBX 125
i
3/23/2018Liberum CapitalReiterated RatingHoldGBX 120
i
2/21/2018Peel HuntReiterated RatingBuyGBX 125
i
2/15/2018Liberum CapitalReiterated RatingHoldGBX 120
i
2/15/2018Peel HuntReiterated RatingBuyGBX 125
i
1/18/2018Jefferies Financial GroupReiterated RatingBuyGBX 126
i
1/8/2018Liberum CapitalReiterated RatingHoldGBX 120
i
1/2/2018Peel HuntReiterated RatingBuyGBX 125
i
12/14/2017Liberum CapitalReiterated RatingHoldGBX 120
i
12/5/2017Peel HuntReiterated RatingBuyGBX 125
i
11/29/2017Jefferies Financial GroupInitiated CoverageBuyGBX 125
i
8/2/2017Liberum CapitalReiterated RatingHoldGBX 120
i
7/27/2017Liberum CapitalReiterated RatingHoldGBX 120
i
7/27/2017Peel HuntReiterated RatingBuyGBX 125
i
4/20/2017Peel HuntReiterated RatingBuyGBX 125
i
4/20/2017Liberum CapitalReiterated RatingHoldGBX 110
i
3/13/2017Liberum CapitalLower Price TargetHoldGBX 120 ➝ GBX 110
i
2/16/2017Liberum CapitalReiterated RatingHoldGBX 120
i
2/16/2017Peel HuntReiterated RatingBuyGBX 125
i
2/3/2017Liberum CapitalReiterated RatingHoldGBX 120
i
11/1/2016Liberum CapitalReiterated RatingHoldGBX 120
i
7/27/2016Peel HuntReiterated RatingBuyGBX 125
i
7/27/2016Liberum CapitalReiterated RatingHoldGBX 112
i
7/20/2016Peel HuntReiterated RatingBuyGBX 125
i
7/4/2016Liberum CapitalReiterated RatingHoldGBX 112
i
5/20/2016Peel HuntReiterated RatingBuy
i
4/27/2016Liberum CapitalReiterated RatingHold
i
4/15/2016Peel HuntReiterated RatingBuy
i
3/22/2016Liberum CapitalReiterated RatingHold
i
(Data available from 2/27/2016 forward)
Primary Health Properties PLC (PHP.L) logo
Primary Health Properties (PHP) is the leading investor in modern healthcare properties in the UK & Ireland. PHP is a UK based Real Estate Investment Trust (REIT) with a clear objective to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. PHP achieve this by investing in healthcare real estate let on long-term leases, backed by a secure underlying covenant funded mostly by government bodies. The Group's portfolio comprises over 480 primary healthcare facilities, both completed and committed, the majority of which are GP surgeries, with other properties let to NHS organisations, pharmacies and dentists.
Read More

Today's Range

Now: GBX 152
150.60
153.20

50 Day Range

MA: GBX 148.91
145.20
157.40

52 Week Range

Now: GBX 152
120.40
167.60

Volume

5,241,876 shs

Average Volume

3,959,096 shs

Market Capitalization

£2.02 billion

P/E Ratio

17.47

Dividend Yield

4.07%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Primary Health Properties PLC (PHP.L)?

The following Wall Street analysts have issued research reports on Primary Health Properties PLC (PHP.L) in the last year: Barclays PLC, Berenberg Bank, Jefferies Financial Group Inc., Liberum Capital, and Peel Hunt.
View the latest analyst ratings for PHP.

What is the current price target for Primary Health Properties PLC (PHP.L)?

4 Wall Street analysts have set twelve-month price targets for Primary Health Properties PLC (PHP.L) in the last year. Their average twelve-month price target is GBX 168, suggesting a possible upside of 10.5%. Peel Hunt has the highest price target set, predicting PHP will reach GBX 175 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of GBX 155 for Primary Health Properties PLC (PHP.L) in the next year.
View the latest price targets for PHP.

What is the current consensus analyst rating for Primary Health Properties PLC (PHP.L)?

Primary Health Properties PLC (PHP.L) currently has 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PHP will outperform the market and that investors should add to their positions of Primary Health Properties PLC (PHP.L).
View the latest ratings for PHP.

What other companies compete with Primary Health Properties PLC (PHP.L)?

Other companies that are similar to Primary Health Properties PLC (PHP.L) include Chartwell Retirement Residences, NorthWest Health Prop Real Est Inv Trust, Assura, Impact Healthcare REIT and Medicx Fund.

How do I contact Primary Health Properties PLC (PHP.L)'s investor relations team?

Primary Health Properties PLC (PHP.L)'s physical mailing address is 5th Fl, Greener House, 66-68 Haymarket, LONDON, SW1Y 4RF, United Kingdom. The real estate investment trust's listed phone number is +44-20-71045599. The official website for Primary Health Properties PLC (PHP.L) is www.phpgroup.co.uk.